ACOR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ACOR shares is 23, representing 13.22% of the company's common stock.

N/A, in the last quarter, reduced its stake in ACOR by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the ACOR shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ACOR shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, BNP PARIBAS ARBITRAGE, SNC increased its stake in ACOR by 100% in the last quarter. The institutional holder raised its holding to 7.79 thousand shares having worth more than $4.01K. N/A also added N/A more shares of ACOR to its portfolio, raising its holding to - shares of worth -. N/A also increased its ACOR shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in ACOR is SCOPIA CAPITAL MANAGEMENT LP , 10 percent owner at the company. Additionally, ACOR stock is highly held by President and CEO COHEN RON and President, Intl and GC Wasman Jane among others.

Company executives, directors, and other insiders own 0.69% percent of Acorda Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ACOR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COHEN RON, WASMAN JANE, and SABELLA LAUREN M.

There have been 0 transaction(s) during the past 6-months in which Acorda Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Acorda Therapeutics, Inc. shares are held by insiders, which represents about 0.69% of ACOR stock.

ACOR 10 percent owner, SCOPIA CAPITAL MANAGEMENT LP holds the largest portfolio of the company's shares. ACOR shares owned by SCOPIA total nearly 4.75 million.

BNP PARIBAS ARBITRAGE, SNC is the largest institutional owner in ACOR which holds 7.79 thousand shares worth $4.01K or 1.4% of the total ACOR shares outstanding followed by N/A with ownership of - shares representing N/A of the ACOR ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ACOR is concerned, it is a stock which is not optionable.

Number of ACOR shares short is 8.10K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 1.24M shares of ACOR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ACOR has 1.22M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ACOR is 1.84.